Rene Sindlev, Director, 10% Owner at Enochian Biosciences Inc (ENOB), bought 1,400,661 shares at $8.00 ($2.4M) on 2018-12-27, disclosed to the SEC on 2018-12-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.30 | 1,307,693 | $1.7M | 69.6% |
| 2 | $8.00 | 92,968 | $744K | 30.4% |
| Total | $1.74 avg | 1,400,661 | $2.4M | 100% |
| Filing → |
| ENOB | BUY | 2019-06-05 | $132K | — | Filing → |
| ENOB | BUY | 2019-06-05 | $31K | — | Filing → |
| ENOB | BUY | 2019-06-05 | $268K | — | Filing → |